CDC Division of Global HIV & TB Country Profile: Cote D’ Ivoire: July 2018

Details

• Corporate Authors:
  Center for Global Health (U.S.). Division of Global HIV & TB. ; U.S. President's Emergency Plan for AIDS Relief.
• Description:
  S T R A T E G I C F O C U S
  
  The U.S. Centers for Disease Control and Prevention (CDC) began its partnership with Côte d’Ivoire in 1987 by opening the Project Retrovirus Côte d'Ivoire (Retro-CI) laboratory in collaboration with the Ivoirian health ministry. In 2004, this partnership expanded when the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) started providing services in Côte d'Ivoire.
  
  Today, Côte d’Ivoire has made significant progress with providing treatment to those who know they have HIV: 88% of them are on antiretroviral treatment (ART), and almost 80% of those on treatment are virally suppressed based on the 2018 Population Health Impact Assessment (PHIA). However, AIDS is still one of the top causes of mortality in Côte d'Ivoire, with only about 4 in 10 adults with HIV knowing their status.
  
  
• Subjects:
  Global Health HIV Infections/prevention & Control Public Health Tuberculosis/prevention & Control
• Series:
  CDC Division of Global HIV & TB Country Profile
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  Cote D' Ivoire
• Pages in Document:
  1 unnumbered page
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:78f0fda34d5278163f72a0e85327fbc2fe24be2cd9c64d4761c213daf2b254216912a43e7be7ef912ce9fd0b282df7ca247b514da672149cd7decd0b075aeaf0
• Download URL:
  https://stacks.cdc.gov/view/cdc/60081/cdc_60081_DS1.pdf
• File Type:
  [PDF - 288.32 KB ]